H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) shares passed below its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Price Performance
The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32. The stock’s fifty day moving average price is $22.00 and its two-hundred day moving average price is $22.00. The firm has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68.
H. Lundbeck A/S Company Profile
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Featured Stories
- Five stocks we like better than H. Lundbeck A/S
- With Risk Tolerance, One Size Does Not Fit All
- Is McDonald’s Stock Serving a Value Meal to Investors?
- How to Calculate Options Profits
- Walgreens Comeback? Private Equity Circling for a Buyout
- How to Start Investing in Real Estate
- Coca-Cola Stock Looks Refreshing After the Relief Rally
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
